Detalles de la búsqueda
1.
Platelet count doubling after the first cycle of azacitidine therapy predicts eventual response and survival in patients with myelodysplastic syndromes and oligoblastic acute myeloid leukaemia but does not add to prognostic utility of the revised IPSS.
Br J Haematol
; 167(1): 62-8, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24995683
Resultados
1 -
1
de 1
1
Próxima >
>>